US Food and Drug Administration
Dr. Yajun Liu, Ph.D., is currently a reviewer in the Division of Cancer Pharmacology II, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, at US Food and Drug Administration. She earned her dotoral degree in Pharmaceutical Science from the University of Michigan and bachelor degree in Pharmacy from Shanghai Jiaotong University in China. She currently reviewes the clinical pharmacology aspects of the developmental program (IND/NDA/BLA) of oncology drug products.